In vivo reprogramming leads to premature death linked to hepatic and intestinal failure
Alberto Parras, Alba Vílchez-Acosta, Gabriela Desdín-Micó, Sara Picó, Calida Mrabti, Elena Montenegro-Borbolla, Céline Yacoub Maroun, Amin Haghani, Robert T. Brooke, María del Carmen Lapo Maza, Cheyenne Rechsteiner, Fabrice Battiston, Clémence Branchina, Kevin Pérez, Steve Horvath, Claire Bertelli, Christine Sempoux, Alejandro Ocampo
Topics & Concepts
ReprogrammingIn vivoCell biologyCancer researchMedicineBiologyChemistryGeneticsCellPluripotent Stem Cells ResearchMetabolism and Genetic DisordersPancreatic function and diabetes